AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines
Dana S. Levy(GlaxoSmithKline (United States)), Rakesh Kumar(GlaxoSmithKline (United States))
Cited by 165
Related Papers
Insulin-like Growth Factor Receptor as a Therapeutic Target in Head and Neck Cancer
|Clinical Cancer Research|2007|141
WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma
|PLoS ONE|2015|67